Editing GSK plc (section)

===Scientific recognition===
Four GlaxoSmithKline scientists have been recognized by the Nobel Committee for their contributions to basic medical science and/or therapeutics development.
* [[Henry Hallett Dale|Henry Dale]], a former student of [[Paul Ehrlich]], received the 1936 [[Nobel Prize in Medicine]] for his work on the chemical transmission of neural impulses. Dale served as a pharmacologist and then as Director of the Wellcome Physiological Research Laboratories from 1904 to 1914, and later served as Trustee and chairman of the board of the [[Wellcome Trust]].<ref>{{Cite web |title=The Nobel Prize in Physiology or Medicine 1936 |url=https://www.nobelprize.org/prizes/medicine/1936/dale/biographical/ |url-status=live |archive-url=https://web.archive.org/web/20180826193351/https://www.nobelprize.org/prizes/medicine/1936/dale/biographical/ |archive-date=26 August 2018 |website=NobelPrize.org}}</ref>
* [[John Vane]] of Wellcome Research Laboratories shared the 1982 Nobel Prize for Medicine for his work on prostaglandin biology and the discovery of [[prostacyclin]]. Vane served as group research and development director for The Wellcome Foundation from 1973 to 1985.<ref>{{Cite web |title=The Nobel Prize in Physiology or Medicine 1982 |url=https://www.nobelprize.org/prizes/medicine/1982/vane/biographical/ |url-status=live |archive-url=https://web.archive.org/web/20190220002730/https://www.nobelprize.org/prizes/medicine/1982/vane/biographical/ |archive-date=20 February 2019 |website=NobelPrize.org}}</ref>
* [[Gertrude B. Elion]] and [[George Hitchings]], both of the Wellcome Research Laboratories, shared the 1988 Nobel Prize in Medicine with [[Sir James W. Black]], formerly of Smith Kline & French and the Wellcome Foundation, ""for their discoveries of important principles for drug treatment"." Elion and Hitchings were responsible for the discovery of a plethora of important drugs, including mercaptopurine<ref name="pubs.acs.org"/> and thioguanine<ref name="ScienceHistory"/> for the treatment of leukemia, the immunosuppressant azothioprine,<ref>{{cite journal |title=Azathioprine: old drug, new actions |pmc=152947 |pmid=12697731 |doi=10.1172/JCI18384 |volume=111 |issue=8 |date=April 2003 |journal=J. Clin. Invest. |pages=1122–4 |vauthors=Maltzman JS, Koretzky GA}}</ref> allopurinol for gout,<ref name="The purine path to chemotherapy"/> pyrimethamine for malaria,<ref name="nytimes.com"/> the antibacterial trimethoprim,<ref name="ScienceHistory"/> acyclovir for herpes virus infection,<ref>{{cite journal |vauthors=Elion GB |title=Acyclovir: discovery, mechanism of action, and selectivity |journal=J. Med. Virol. |volume=Suppl 1 |pages=2–6 |year=1993 |pmid=8245887 |doi=10.1002/jmv.1890410503 |s2cid=37848199}}</ref> and nelarabine for cancer treatment.<ref>{{cite journal |vauthors=Koenig R |title=The legacy of great science: the work of Nobel Laureate Gertrude Elion lives on |journal=Oncologist |volume=11 |issue=9 |pages=961–5 |year=2006 |pmid=17030634 |doi=10.1634/theoncologist.11-9-961}}</ref>